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The aim of this study was to determine the impact of introducing a clinical pharmacist led discharge 
service on medication safety at the point of discharge and its acceptability to healthcare staff. 
 
Methods 
A retrospective chart review to identify medication discrepancies was undertaken before and after 
the introduction of a pharmacist led discharge service. An evaluation was undertaken by means of a 
questionnaire to community pharmacists, GPs and hospital clinicians. 
 
Results 
The pharmacist led discharge service significantly reduced errors from 50% (n=17) to 7% (n=2) of 
patients (p<0.001) and 10% (n=22) to 1% (n=2) of medication orders (p=0.001). The evaluation 
revealed that the majority of clinicians found the service useful, had the potential to reduce errors 
and improve communication. 
 
Conclusion 
Pharmacist involvement at the point of discharge had a significant impact on medication safety. 
Crucially, in this project, we show the service was received well by medical personnel and improved 
communication between primary and secondary care, enhancing implementation potential. 
 







It has been suggested that one of the greatest risks to patient safety occurs when the patient passes 
across the boundaries of care, whether between professionals or between organisations1-2. 
Medication reconciliation has been proposed3 and the inclusion of clinical pharmacists and physicians 
in the process shown to enhance patient safety4. 
 
In the Republic of Ireland, hospital pharmacists are not routinely involved in the discharge process5. 
The discharge medication list is transcribed, usually by the most junior doctor of the treating team, 
onto the discharge prescription and the discharge summary for the patient’s community pharmacist 
and general practitioner (GP), respectively. This process raises concerns as medication errors at the 
point of discharge are common, affecting 11%-66% of patients6-12. Furthermore, adverse drug events 
represent the most frequent cause of patient harm post discharge and approximately one-third of 
these are the result of preventable errors2,13. The risk of re-admission is also increased. Williams and 
Fitton reported that 59% of unplanned re-admissions could have been prevented with improved 
discharge planning, including providing timely and accurate information to the GP and more effective 
management of medication14. Medication safety, including effective communication between care 
environments, is therefore of vital importance.   
 
The aim of this study was to determine the impact of introducing a clinical pharmacist led discharge 





Medication discrepancies were those identified if the medication list across the admissions drug 
history, inpatient prescription chart, discharge prescription and medication list on the discharge 
summary revealed an inconsistency, and the reason for such was not clinically apparent and/or 
documented in the patient notes. Omission of medication prescribed on a “when required basis” 
during inpatient stay was not recorded as a discrepancy. A prescribing error was defined as a 
prescribing decision or prescription writing process that results in an unintentional, significant 
reduction in the probability of treatment being timely and effective or increase in the risk of harm, 
when compared with generally accepted practice15. Any medication discrepancy detected by the 
pharmacist was discussed with the prescribing doctor and if unintentional, was recorded as a 
prescribing error.              
 
Phase 1 consisted of normal practice, where the treating doctor hand wrote the prescription and hand 
wrote the discharge medication list onto the discharge summary. The pharmacist was not involved in 
the discharge process. In phase 1, over a three-week period, a retrospective clinical review of the 
discharge medication lists was undertaken by the pharmacist, reconciling the pre-admission 
medication and inpatient prescription chart with the discharge medication lists. Any 
discrepancies/prescribing errors identified were discussed with the treating team. Patients who were 
discharged from the study ward during pharmacy business hours and received reconciliation of pre-
admission medication by a clinical pharmacist were included. 
 
As part of the pilot introduction of a pharmacist led service (phase 2), electronic prescription and 
medication report (see supplementary material) forms were designed for the patient’s community 
pharmacist and GP. In addition to the standard information required for a prescription, the electronic 
format included information on allergies, notes relevant to the discharge medication and changes to 
pre-admission medication made during the inpatient stay. The medication report also included 
reasons for changes made to pre-admission medication, as well as indications for the discharge 
medications prescribed. Both documents were generated simultaneously with single data entry. The 
pharmacist generated the documents, reconciling the pre-admission medication with the inpatient 
prescription chart and undertaking a clinical medication review.  
 
The doctor from the treating team reviewed both documents electronically and if an amendment was 
required, the pharmacist was contacted. When satisfied, the doctor printed, signed and dated both 
documents as per legal requirements. Controlled drug prescriptions and discharges out of pharmacy 
hours were completed by the doctor in the traditional handwritten format.  Patients included were 
those who were under the care of the endocrinology and the gastroenterology teams, were discharged 
from the study ward during pharmacy business hours and received reconciliation of pre-admission 
medication by a clinical pharmacist.  
 
In phase 2, over a five-week period, a clinical review of the discharge medication lists was undertaken 
by the pharmacist, reconciling the pre-admission medication and inpatient prescription chart with the 
pharmacist then creating an accurate discharge medication list. A retrospective review was 
undertaken post discharge by a senior pharmacist of the discharge medication lists generated by the 
pharmacist.  
 
Anonymous study evaluation data was extracted retrospectively by the pharmacist for both phases. 
While part of the clinical treatment of patients, data was identifiable to those on the treating team. 
The data extracted for use in the research component was anonymous with only aggregated fully 
anonymous data extracted.  
 
It was intended to use the same study period for both phase 1 and phase 2 data collection, however, 
as only two units were included due to training time constraints in phase 2, the study period was 
extended due to lower patient through-put. 
 
Prescribing errors were independently reviewed and categorised into their potential to cause patient 
harm by a panel consisting of two medical consultants, two senior pharmacists and a clinical nurse 
manager using the Dean & Barber visual analogue scale16. A mean score of 8-10 had the potential to 
cause severe patient harm, 3-7 moderate or <3 minor/ no harm.   
 
In order to evaluate the service introduced, a questionnaire was developed and sent along with the 
prescription and medication report via the patient to the community pharmacist and GP, respectively. 
A questionnaire was also completed by the hospital doctors who participated in the study.  
Questionnaires were returned on an anonymous basis. 
 
Analysis was carried out using the SPSS Statistics Package Version 17. Chi-squared analysis was used 
to compare proportions between Phase 1 and Phase 2. Analysis of variance (ANOVA) was undertaken 
to compare the mean number of errors between phases. Regression analysis was undertaken to 
determine the relationship between the number of errors and number of medications listed. A p-value 





A total of 62 patients were included in the study: 34 patients in the Phase 1 and 28 in the Phase 2. 
Table 1 compares the baseline characteristics of discharge medication lists completed by the doctor 
to those completed by the pharmacist.  
 
Table 1: Baseline Characteristics. 
 
 Phase 1 Phase 2 
Number of patients 34 28 
Mean age (median; range) 70 (77.5; 37-90) 62.6 (67; 25-90) 
Mean duration of stay (median; range) 12 (9.5; 1-33) 10.7 (5.5; 1-77) 
Mean number of med orders (total) 6.5 (222) 7.4 (208) 
 
The proportion of patients and medication orders affected by a prescribing error is illustrated in Table 
2. A total of 22 and 18 errors were detected on the doctor written prescriptions (phase 1) and 
discharge summaries (phase 2), respectively. Of these, 61.5% were judged to have the potential to 
cause moderate patient harm and 38.5% minor/no harm.   Omissions were the most frequently 
occurring errors (Figure 1). Examples of errors are provided (Table 3).    
 
Table 2: Patients/medication orders affected by discharge prescribing error(s). 
 






Patients 17 (50) 2 (7.1) <0.001   
Med orders   22 (9.9)    2 (0.96) 0.001 
         
Figure 1: Types & frequency of errors per prescription & discharge summary/ medication report. 
 
 
Table 3: Examples of errors detected. 
 





history     
Inpatient 






Moderate harm        n/a Aspirin 75 mg 
daily    
  Omitted                  Omitted NSTEMI 
Moderate harm        Novomix 30 bd Novomix 30 bd   Omitted                  Omitted Type 2 diabetes 
Moderate harm        n/a Atorvastatin 10 
mg nocte 
  Omitted                  Omitted NSTEMI 





history     
Inpatient 






Moderate harm        Vitamin B12 inj. 
monthly 
Omitted Omitted Omitted Vitamin B12 
deficiency 
Moderate harm        Nebivolol 5 mg 
bd 
Nebivolol 5 mg 
bd 
Nebivolol 5 mg 
daily 




Two errors, one omission and one error of frequency were detected, by the senior pharmacist’s 
retrospective review of the pharmacist’s generated lists (phase 2). Both were considered to have the 
potential to cause moderate patient harm. In one case, corrective action was taken by contacting the 
patient’s GP. The errors that occurred are listed (Table 3). No errors/amendments were 




Thirteen community pharmacists (46%) completed the survey. In terms of the content of the new 
prescription format, 31% found it useful and appropriate and 69% found it very useful and appropriate. 
All were of the view that it had the potential to reduce the risk of medication errors and all felt it 
improved communication between secondary and primary care. The majority (85%) considered that 
the additional information on medication changes and allergies/adverse reactions should accompany 
all discharge prescriptions. 
 
In particular, community pharmacists noted the avoidance of confusion:  
 
“Many patients are confused about their medications when they are discharged and we regularly have 
to phone to clarify”, “Printed prescription and clear indication of change to medicines will definitely 
help to reduce risk of medication errors”. 
 
Eleven completed (39%) GP questionnaires on the medication report were returned. In terms of the 
content of the new prescription format, 18% found it useful and appropriate, 73% found it very useful 
and appropriate while the remaining 9% found it partly useful and appropriate. All GP respondents 
were of the view that it had the potential to reduce the risk of medication errors, that it improved 
communication between secondary and primary care and that the information should accompany all 
discharge summaries. 
GPs referred to patient safety improvements:  
 
“List of changes to pre-admission medication very useful”, “Much enhances safety of prescribing”, “The 
communication of discharge medicines is of vital importance”. 
 
All five relevant doctors completed the hospital clinician questionnaire regarding the pharmacist led 
discharge service. All agreed that the pharmacist led discharge service saved a significant amount of 
time, reduced the risk of medication error and improved patient adherence: 
 
“Safer, ensures correct medications, encourages compliance, informs GPs”, “Time saved in doing 
patient discharge. Also saves on unnecessary calls from GPs asking about changes in medications”. 
“Patients more aware of the medication they are taking and dosing regimens”, “Patient has better 
understanding of the indication of each medication and when they present to outpatient clinics or 
Accident and Emergency have a legible record of all current medications”. 
 
According to respondents, the most positive aspects of the service were:  
 
“Reduces risk of errors on prescriptions”, “Time saving” and “Safety – pharmacist is very thorough at 






Overall, 50% of patients were affected by at least one prescribing error on the doctor written discharge 
medication lists. While high, this is lower than that reported elsewhere in the Republic of Ireland and 
abroad, up to 66%7,11. The number of medication orders affected, 10%, was similar to that reported 
elsewhere in Ireland and in the UK11,17,18. 
 
The pharmacist led service resulted in a significant reduction in the proportion of patients affected 
(50% to 7%) and is comparable to that reported in the UK: 32% to 8%19. The reduction in discharge 
medication orders affected, from 10% to 1% was also statistically significant.   
 
The questionnaires returned by the doctors involved in the pharmacist led service highlight the 
significant impact made and the need to develop pharmacist involvement in this area.    
 
The survey data highlights the problems inherent in the traditional discharge process: patients are 
often confused about their medicines post discharge, medicines not relating to stay in hospital are 
omitted from prescriptions and community pharmacists frequently have to phone to clarify discharge 
medication. Therefore, enhanced communication between healthcare sectors is required, as 
previously identified in the UK20-21.  
 
As part of the pharmacist led discharge service, discharge medication lists were generated 
electronically. It is important to highlight that electronic prescribing support was not provided as data 
required manual entry.  
Studies that have shown error reduction with electronic systems utilised comprehensive prescribing 
support22-24.  Use of the electronic system did however reduce transcription burden, which has been 
associated with reduced error rate25. How significant this was in influencing the error rate on the 
pharmacist led service is unknown.  
 
The response rate to the surveys on the new prescription format and medication report was moderate 
for both community pharmacists (46%) and GPs (39%). A limitation to the method of distribution was 
that patients were responsible for delivering the survey to their community pharmacy and GP. 
Therefore, it is not known whether all surveys were distributed. As surveys were fully anonymous, 
there was no follow up of non-responders. The survey results are based on a self-selecting sample 
which comes with inherent bias. This study was conducted in a real-world setting and was not designed 
to show causation; the patients included were a presenting sample over the study timeframe. A 
further limitation is that an economic assessment was not undertaken. 
 
Pharmacist involvement at the point of discharge had a significant impact on medication safety. The 
pharmacist-led discharge service conferred a number of additional benefits: providing additional 
important information for the community pharmacist and GP, time saving for discharging doctors and 
improved use of pharmacist expertise. The importance of pharmacist involvement from admission to 
discharge and the benefits of a team-based approach in Ireland is supported by published evidence4. 
Crucially, in this project, we show that the service was received well by medical personnel and 
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